Journal of Circulating Biomarkers to sponsor Cambridge Healthtech's "microRNA as Biomarkers" and "Diagnostics and Extracellular RNA in Drug and Diagnostic Development" meetings
November 20, 2015
The Journal of Circulating Biomarkers (JCB) will be presented and is included among the media sponsors of the 12th Annual "microRNA as Biomarkers and Diagnostics" conference and the 2nd Annual "Extracellular RNA in Drug and Diagnostic Development" conference.
These 2 events will take place on April 4-6, 2016, at the Hyatt Regency in Cambridge (USA), and are organised by Cambridge Healthtech Institute, a division of the Cambridge Innovation Institute.
The "microRNA as Biomarkers and Diagnostics" meeting will cover the latest research in the use of microRNAs for early detection of disease, monitoring cancer progression and therapeutic response, and understanding immunity. During this meeting, one of JCB’s Editors-in-Chief, Dr. Shidong Jia (Genentech Inc, South San Francisco, USA), will hold a lecture titled "Clinical Evaluation of Circulating Biomarkers in Precision Medicine”. Dr. Jia will be joined at this event by JCB’s Editorial Board Member Dolores Di Vizio (Harvard Medical School, USA), who will speak about "Large Oncosomes: New Frontiers for Cell-to-Cell Communication in Cancer”.
The "Extracellular RNA in Drug and Diagnostics Development" meeting will focus on the latest research in this emerging area of non-invasive diagnostics, including exosomes and microvesicles, circulating microRNA and other non-coding RNA, and issues of standardization, profiling, and data analysis.
If you are interested in participating in these events, you will be granted a 15% discount on the registration fee when using the following discount code: JCB15.
To register and use the code, please click here.
For more information regarding these meetings and the program, please follow this link.
Further details about our Journal of Circulating Biomarkers can be found here.